Chronic blockade of nitric oxide biosynthesis in rats: Effect on leukocyte endothelial interaction and on leukocyte recruitment

Inflammation Research

Volumn 53, Issue 9, 2004, Pages 442-452

  Farsky, S H P ^a   Borelli, P ^a   Fock, R A ^a   Proto, S Z ^b   Ferreira Jr , J M C ^c   Melo, S B V ^b  

^a Univ S Paulo Av B   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

Haematological parameters; Inflammation; Leukocyte endothelial interactions; Microcirculation; Nitric oxide

Indexed keywords

ACETYLCHOLINE; BATROXOBIN; BETA2 INTEGRIN; L SELECTIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BLOOD FLOW; BLOOD SMEAR; BLOOD VESSEL REACTIVITY; BONE MARROW CELL; CELL INFILTRATION; CELL INTERACTION; CELL MOTILITY; CHEMICAL REACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EVALUATION; FLOW CYTOMETRY; HEMATOLOGICAL PARAMETERS; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; MAST CELL; MICROCIRCULATION; MICROSCOPY; NONHUMAN; OBSERVATION; POLYMORPHONUCLEAR CELL; PROTEIN EXPRESSION; RAT;

ANIMALS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INFLAMMATION; L-SELECTIN; MALE; MICROCIRCULATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 6044257383     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1288-7     Document Type: Article

References (67)

1. Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993; 110: 701-6.
2. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749-54.
3. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995; 22: 1922-8.
4. Medeiros MV, Binhara IM, Moreno JH, Zatz R, De Nucci G, Antunes E. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. Eur J Pharmacol 1995; 285: 109-14.
5. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995; 114: 1171-8.
6. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996; 118: 829-38.
7. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995; 96: 301-8.
8. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651-60.
9. Palácios FA, Novaes GS, Guzzo ML, Laurindo IM, Mello SB. Interrelationship of the kinin system, nitric oxide and eicosanoids in the antigen-induced arthritis in rabbits. Mediators Inflamm 1999; 8: 245-51.
10. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-5.
11. Arndt H, Russell JB, Kurose I, Kubes P, Granger DN. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric-oxide synthesis. Gastroenterology 1993; 105: 675-80.
12. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994; 107: 1050-8.
13. Kubes P, Sihota E, Hickey MJ. Endogenous but not exogenous nitric oxide decreases TNF-alpha-induced leukocyte rolling. Am J Physiol 1997; 273: G628-35.
14. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293-9.
15. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993; 265: H862-7.
16. Niu XF, Ibbotson G, Kubes P. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ Res 1996; 79: 992-9.
17. Kwasniewski FH, Tavares de Lima W, Bakhle YS, Jancar S. Endogenous nitric oxide does not modulate mesenteric mast cell degranulation in rats. Biochem Pharmacol 2003; 65: 2073-80.
18. Peh KH, Moulson A, Wan BY, Assem EK, Pearce FL. Role of nitric oxide in histamine release from human basophils and rat peritoneal mast cells. Eur J Pharmacol 2001; 425: 229-38.
19. Brooks AC, Whelan CJ, Purcell WM. Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition. Br J Pharmacol 1999; 128: 585-90.
20. Kimura M, Mitani H, Bandoh T, Totsuka T, Hayashi S. Mast cell degranulation in rat mesenteric venule: effects of L-NAME, methylene blue and ketotifen. Pharmacol Res 1999; 39: 397-402.
21. Scalia R, Appel JZ 3rd, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 1998; 18: 1093-100.
22. Mitchell DJ, Yu J, TymL K. Local L-NAME decreases blood flow and increases leukocyte adhesion via CD18. Am J Physiol 1998; 274: H1264-8.
23. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-8.
24. Adams MR, Jessup W, Hailstones D, Celermajer DS. L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997; 95: 662-8.
25. Hickey MJ. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci (Lond) 2001; 100: 1-12.
26. Lee SK, Kim JH, Yang WS, Kim SB, Park SK, Park JS. Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role of cyclic GMP and NF-kappaB. Nephron 2002; 90: 447-54.
27. Selleri C, Maciejewski JP. Nitric oxide and cell survival: megakaryocytes say 'NO'. J Lab Clin Med 2001; 137: 225-30.
28. Geffher JR, Trevani AS, de D'Elia I, Diament M, Klein D, Giordano M. Involvement of nitric oxide in the regulation of peripheral blood leukocyte counts. J Leukoc Biol 1995; 58: 391-4.
29. Lund-Johansen F, Terstappen LW. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 1993; 54: 47-55.
30. Mello SBV, Novaes GS, Laurindo IMM, Maciel FMB, Cossermelli W. NOS inhibition influences eicosanoids and Interleukin 1 production in experimental arthritic joint. Inflamm Res 1997; 46: 72-7.
31. Guzzo ML, Farsky SH, De Nucci G, Antunes E, Silva MA, Mello SB. Role of kinins and nitric oxide on the rabbit arthritis induced by Bothrops jararaca venom. Toxicon 2000; 38: 1535-46.
32. Mello SB, Guzzo ML, Lisboa LF, Farsky SH. Pharmacological characterisation of arthritis induced by Bothrops jararaca venom in rabbits: a positive cross talk between bradykinin, nitric oxide and prostaglandin E2. Mediators Inflamm 2002; 11: 13-6.
33. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme J. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes 1991; 40: 1267-73.
34. Farsky SP, Sannomiya P, Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J Leukoc Biol 1995; 57: 379-86.
35. Borders JL, Granger HJ. An optical doppler intravital velocimeter. Microvasc Res 1984; 27: 117-17.
36. Davis MJ. Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc.Res 1987; 34: 223-30.
37. Van Kampen EJ, Zijstra WG. Standardization of hemoglobinometry II. The hemoglobin cyanide methods. Clin Chem Acta 1961; 6: 538-43.
38. Brown BA. In: Lea, Febiger (Eds), Hematology, Principles and practice, Fourth Edition, Philadelphia, 1984.
39. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-37.
40. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 1999; 31: 651-69.
41. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992; 20: 298-303.
42. Navarro J, Sanchez A, Saiz J, Ruilope LM, Garcia-Estan J, Romero JC et al. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994; 267: R1516-21.
43. Moreno H Jr, Piovesan NL, Pereira Costa SK, Metze K, Antunes E, Zatz R et al. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol. 1995; 287: 93-6.
44. De Gennaro Colonna V, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F et al. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol 2002; 450: 61-6.
45. Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 1996; 32: 699-708.
46. Yamaki K, Thorlacius H, Xie X, Lindbom L, Hedqvist P, Raud J. Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998; 123: 390-9.
47. Baldwin AL, Thurston G, al Naemi H. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am J Physiol 1998; 274: H1776-84.
48. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995b; 96: 301-8.
49. Paya M, Garcia PP, Coloma J, Alcaraz MJ. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Br J Pharmacol 1997; 120: 1445-52.
50. Gad MZ, Khattab M. Modulation of nitric oxide synthesis in inflammation. Relationship to oxygen-derived free radicals and prostaglandin synthesis. Arzneimittelforschung 2000; 50: 449-55.
51. Herencia F, Ferrandiz ML, Ubeda A, Guillen I, Dominguez JN, Charris JE et al. 4-dimethylamino-3′,4′-dimethoxychalcone downregulates iNOS expression and exerts anti-inflammatory effects. Free Radic Biol Med 2001; 30: 43-50.
52. Kaplan SS, Billiar T, Curran RD, Zdziarski UE, Simmons RL, Basford RE. Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood 1989; 74: 1885-7.
53. Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993; 122: 388-94.
54. VanUffelen BE, de Koster B, Van den Broek MPJ, VanSteveninck J, Elferink JG. Modulation of neutrophil migration by exogenous gaseous nitric oxide. J Leukoc Biol 1996; 60: 94-100.
55. Zanardo RC, Costa E, Ferreira HH, Antunes E, Martins AR, Murad F et al. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proc Natl Acad Sci USA 1997; 94: 14111-4.
56. Biffl WL, Moore EE, Moore FA, Barnett C. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res 1996; 63: 328-32.
57. Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 1996; 8: 817-21.
58. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999; 276: H1943-50.
59. Conran N, Gambero A, Ferreira HH, Antunes E, de Nucci G. Nitric oxide has a role in regulating VLA-4-integrin expression on the human neutrophil cell surface. Biochem Pharmacol 2003; 66: 43-50.
60. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002; 21: 3295-313.
61. Lotem J, Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 2002; 21: 3284-94.
62. Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 2002; 9: 183-9.
63. Selleri C, Sato T, Raiola AM, Rotoli B, Young NS, Maciejewski JR Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br J Haematol 1997; 99: 481-9.
64. Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF et al. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 1995; 96: 1085-92.
65. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood; 1990; 76(12): 2483-92.
66. Lund-Johansen F, Terstappen LW. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 1993; 54: 47-55.
67. Terstappen LW, Candour D, Huang S, Lund-Johansen F, Manion K, Nguyen M et al. Assessment of hematopoietic cell differentiation by multidimensional flow cytometry. J Hematother 1993; 2(3): 431-47.